- /
- Supported exchanges
- / US
- / CRL.NYSE
Charles River Laboratories (CRL NYSE) stock market data APIs
Charles River Laboratories Financial Data Overview
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Charles River Laboratories (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Charles River Laboratories data using free add-ons & libraries
Get Charles River Laboratories Fundamental Data
Charles River Laboratories Fundamental data includes:
- Net Revenue: 3 999 M
- EBITDA: 849 M
- Earnings Per Share: -4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Charles River Laboratories Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: 2.98
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Charles River Laboratories News
New
Charles River's Q3 Earnings on Deck: What's in Store for the Stock?
Charles River Laboratories International, Inc. CRL is scheduled to report third-quarter 2026 results on Nov. 4, before market open. In the last reported quarter, the company's adjusted earnings per s...
Healthcare sector rallies in October amid rotation away from technology stocks
Healthcare stocks jumped in October, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) gaining nearly 9.5% as investors rotated out of high-flying technology sha...
Charles River (CRL) Stock Could Be 27% Overvalued As Preclinical FDA Collaboration Starts
Charles River Laboratories International has become a talking point after a sharp multi‑year rally, which naturally raises a harder question for you as an investor: Is the current share price still ...
Charles River Laboratories (CRL) Expands Virtual Control Group Use In Toxicology Studies
Charles River Laboratories International (NYSE:CRL) agreed to deploy its Virtual Control Group database for Ipsen to support toxicology studies and reduce animal use. The Ipsen collaboration uses AI p...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.